Residents of Austria regard the Russian Sputnik V coronavirus vaccine with greater confidence than the AstraZeneca vaccine, according to a study by the Institute for Management and Economic Research of Austria (IMWF Austria).
“Even the as-yet-unapproved Sputnik V vaccine is rated twice as positive in the German-speaking space as the AstraZeneca vaccine, especially in Austria,” the study said.
The Institute conducted a study in January and February 2021, which analyzed about 250 thousand statements about vaccines in three German-speaking countries, Austria, Germany and Switzerland. Analyzed statements from traditional media, blogs, social networks. The sentiment of the statements was divided into positive (+1), neutral (0) and negative (-1).
According to the study, Johnson & Johnson (0.18 tonality) is in first place in terms of approval in German-speaking countries, followed by Pfizer / BioNTech (0.14) and Moderna (0.13). The tone of statements about “Sputnik V” is estimated at 0.11. As noted in the study, positive statements about the Russian vaccine were most often found in social media, in which the vaccine was mentioned 50% more often than in the media. AstraZeneca had a positive tone score of 0.04, and Sinopharm had a 0.03 tone score.
Earlier it was reported that Russian President Vladimir Putin and Austrian Chancellor Sebastian Kurz discussed by phone the issue of supplies to the republic and the joint production of the Sputnik V coronavirus vaccine.
Currently, vaccines from Pfizer / BioNTech, Moderna and AstraZeneca are centrally authorized in the EU market. Vaccination began at the end of December.